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Letters to the EditorThe end question is, independently
of the harvesting technique, are there
segments of ‘‘biologically privileged’’
vein that randomly will have a good
outcome in the long term?
Paulo Roberto B. Evora, MD, PhD
Andrea Carla Celotto, PhD
Department of Surgery and Anatomy
Ribeir~ao Preto Faculty of Medicine
University of S~ao Paulo, BrazilReferences
1. Dreifaldt M, Souza DS, Loesch A, Muddle JR,
Karlsson MG, Filbey D, et al. The ‘‘no-touch’’
harvesting technique for vein grafts in coronary
artery bypass surgery preserves an intact vasa
vasorum. J Thorac Cardiovasc Surg. 2011;141:
145-50.
2. Dashwood MR, Anand R, Loesch A, Souza DS.
Hypothesis: a potential role for the vasa vasorum
in the maintenance of vein graft patency.Angiology.
2004;55:385-95.
3. Parang P, Arora R. Coronary vein graft disease:
pathogenesis and prevention. Can J Cardiol.
2009;25:e57-62.
4. Bilfinger TV, Vosswinkel JA, Rialas CM,
Krukenkamp IB, Stefano GB. Functional assess-
ment of disease-free saphenous vein grafts at redo
coronary artery bypass grafting. Ann Thorac Surg.
2000;69:1183-7.
5. Sueda T, Shikata H, Orihashi K, Kanehiro K,
Kawaue Y, Matsuura Y. Morphological comparison
between arterial grafts and venous grafts. Nippon
Kyobu Geka Gakkai Zasshi. 1994;42:1315-9.
doi:10.1016/j.jtcvs.2011.01.066IS SLIDE TRACHEOPLASTY
ALONE ENOUGH TO IMPROVE
THE SURGICAL OUTCOME?
To the Editor:
We read with interest the report by
Manning and colleagues1 on the series
of 80 patients with congenital tracheal
stenosis undergoing slide tracheo-
plasty (STP).
They conclude that STP, with the use
of cardiopulmonary bypass, is a safe
and reliable technique associated with
low morbidity and mortality. The title
itself underlines the fact that this tech-
nique is also pliable because it could
also be used with extreme anatomic
variants.2 As reported by Manning and
colleagues,1 the age range of patients
undergoing STP can vary from a few
days of life to several years, mainlyThe Journalbecause tracheal stenosis can occur
alone or associated with other anoma-
lies (eg, cardiac, extracardiac, chromo-
somal) that could precipitate the
symptomatology and anticipate the
clinical presentation.When the tracheal
stenosis is isolated, there are different
anatomic variants, such as abnormal
bronchial arborization or functional
single lungs, that can complicate the
preoperative management by requiring
mechanical ventilation (27.5%,1 up to
66%3) and sometimes preoperative ex-
tracorporeal membrane oxygenation to
sustain the hemodynamics.
The use of cardiopulmonary bypass
also is routinely used in our center in
patients with isolated tracheal stenosis
in whom the diameter of the trachea
can be as narrow as 1 or 2 mm and
conventional endotracheal tubes can-
not fit.
The pliability of STP allows the
surgeon to extend the incision into
one of the bronchi when the stenosis
involves segments distal to the ca-
rina.2 However, in the series reported
by Manning and colleagues,1 the in-
volvement of the bronchi in the STP
has not been reported. We believe
that when a stenosis involves the bron-
chi, this must be repaired along with
the trachea.
STP has currently proved its reli-
ability with a better surgical outcome
and lower complication rate when
compared with the other techniques.
We disagree with Manning and col-
leagues’1 statement that the STP itself
is ‘‘largely responsible’’ for their ex-
cellent results.
As reported by our institution, the
management of these complex pa-
tients is multilevel, and intensivists,
surgeons, interventional radiologists,
pneumonologists, and cardiologists
are equally involved. For this reason,
we introduced multidisciplinary man-
agement with a significant improve-
ment of outcome.4
AsManning and colleagues1 report,
42.5% of the patients (34/80) required
at least 1 additional airway interven-
tion, including tracheal dilatation,of Thoracic and Cardiovascular Surgestenting, or reoperation. This indicates
that STP alone does not always work,
because there is still the need for fur-
ther interventions to achieve an ac-
ceptable result.
We believe the management of
patients throughout the follow-up pe-
riod is a key point that must not be
forgotten. A better understanding of
the mid- and long-term effects of tra-
cheal surgery, such as the function of
the airway mucosa or the lung, and
above all on the quality of life, will
be necessary to achieve a thorough
understanding of this very select
population.
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OFF-PUMP VERSUS ON-PUMP
CORONARYARTERY BYPASS
GRAFTING: A META-ANALYSIS
OF PROPENSITY
SCORE–ADJUSTED STUDIES
To the Editor:
We read with great interest the
systematic review and meta-analysis
by Kuss and associates1 of propensity
score analyses, which found on-pump
coronary artery bypass grafting
(CABG) superior to on-pump CABGry c Volume 142, Number 2 475
Letters to the Editorin short-term mortality. A previous
meta-analysis2 of risk-adjusted obser-
vational studies also showed that
off-pump CABG was associated with
reduced early mortality. In terms of
early mortality, however, meta-analy-
ses2,3 of randomized controlled trials
showed no significant difference. In re-
gard to late mortality, previous meta-
analyses2-4of randomized trails demon-
strated thatmortalitywas not reduced in
off-pump CABG. Our newest meta-
analysis5 of randomized trials, however,
suggested that off-pump CABG might
increase late mortality over on-pump
CABG. Meanwhile, a meta-analysis2
of only 2 risk-adjusted observational
studies showed essentially no change
in late mortality. In both early and
late mortality, there has been obvious
discrepancy between evidence from
meta-analyses of randomized trials
and evidence from observational
studies. Moreover, the evidence of
latemortality from themeta-analysis2
of observational studies is insuffi-
cient. To add evidence from observa-
tional studies that represent real-world
clinical practice, we performed aFIGURE 1. Forrest plot of late mortality among pat
Ann Thorac Surg; Circ,Circulation;CJ,Circ J;CJC,
J Thorac Cardiovasc Surg; TCVS, Thorac Cardiovas
476 The Journal of Thoracic and Cmeta-analysis of late (1-year) mortal-
ity adjusted for propensity score in ob-
servational studies of off-pump versus
on-pump CABG.
Our comprehensive search (current
through February 2010) identified 18
propensity score-adjusted observa-
tional studies of off-pump versus on-
pump CABG, which included data
of late (from 1- to 10-year) mortality
on 28,405 patients assigned to off-
pump (n ¼ 13,469) or on-pump (n ¼
14,936) CABG. Pooled analysis dem-
onstrated no significant difference in
late mortality between off-pump and
on-pump CABG in random-effects
models (risk estimate, 0.91; 95% con-
fidence interval, 0.78–1.06; P ¼ .21)
(Figure 1). There was significant
study heterogeneity (P ¼ .04) and lit-
tle difference in the pooled result
from fixed-effects modeling (risk esti-
mate, 0.97; 95% confidence interval,
0.89–1.06; P ¼ .52). Exclusion of
any single study from the analysis
did not substantively alter the overall
result of our analysis. There was no
statistically significant linear relation-
ship between the log risk estimate andients assigned to off-pump versus on-pump CABG. C
Can J Cardiol; CMJ,ChinMed J; EJCTS, Eur J Card
c Surg.
ardiovascular Surgery c August 2011the duration of follow-up in meta-
regression (P ¼ .59 by an unrestricted
maximum likelihood model) or
evidence of significant publication
bias (P ¼ .32 by an adjusted rank-
correlation test).
The results of our analysis suggest
that off-pump CABG may not reduce
late (1-year) mortality over on-pump
CABG. Why is there a discrepancy in
evidence of late mortality between the
meta-analysis5 of randomized con-
trolled trials (superiority of on-pump
CABG) and the present meta-analysis
of propensity score-adjusted observa-
tional studies? Patients enrolled in
randomized trials, commonly with
low-to-moderate risk,may not be repre-
sentative of patients typically seen in
real-world clinical practice. Possible
superiority of off-pump CABG for
high-risk patients included in not
randomized trials but observational
studies may contribute toward equiva-
lent late mortality found in the present
meta-analysis of observational studies.
To confirm whether off-pump CABG
is superior to on-pump CABG for
high-risk patients in late mortality,I, Confidence Interval; IV, inverse variance; ATS,
iothorac Surg; JCVS, J Cardiovasc Surg; JTCVS,
Letters to the Editorrandomized trials in high-risk patients
are needed.
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THE PROBLEM, THERE IS
ALWAYS A SIMPLE
SOLUTION—WHICH IS
WRONG!
To the Editor:
Is it the cough that carries them off?
Asbestos-related pulmonary dis-
ease, and specifically the development
of mesothelioma, continues to be
a tragic health issue. There are charac-
teristics of thewhole disease entity that
seem both unusual but interrelated.
The inhalation of relatively long asbes-
tos fibers is followed by their transport
to the visceral pleura and subsequently
to the parietal pleura and, via lym-
phatics, elsewhere. The fibers produce
subpleural fibrosis in the lungs, but this
discussion relates to the moreThe Journalsignificant parietal pleural changes.
Usually, the first and most diagnostic
appearance is that of pleural plaques,
with or without calcification, at chest
radiograph or computed tomographic
scan. There are several features of
these that warrant consideration.
1. They involve the parietal pleura
and not the visceral.
2. They arise in areas of greatest
movement between the opposing
pleural layers, with respiration,
coughing, and sneezing. They do
not occur over the lung apices or
within the interlobar fissures where
the pleural surfacesmove in unison.
3. The plaques and calcifications tend
to group deep to the ribs. And yes,
some also form over the diaphragm
and pericardium.
A simple question then arises—Is the
development of pleural plaques and
subsequent mesothelioma a result of
chronic abrasive trauma caused by
these fibers at the visceral surface
abraiding the parietal pleura, akin to
oral tumors resulting from ‘‘ill fitting
dentures?’’ This would then infer a me-
chanical etiology rather than a chemical
carcinogenesis and perhaps explain
why other fibers with similar physical
characteristics have also been impli-
catedor areunder suspicion.Of interest,
talc had been viewed with suspicion by
some because of its fiber structure, but
the fact that it produces pleurodesis
would negate any such effect.
If this hypothesis is worthy of con-
sideration, several other points arise.
The negative pressure within the
pleural cavity during quiet respiration,
maintaining the apposition of the vis-
ceral and parietal pleural layers, is
very low, and thiswouldby inference re-
duce abrasive effects. However, during
coughing the glottis closes while the in-
tercostal muscles and abdominal wall
muscles contract, increasing the intra-
thoracic and intrapleural pressurebefore
there is an explosive release of air from
the chest. Themarkedly increaseddirect
pressure exerted by the ribs on the un-
derlying pleural space may explain theof Thoracic and Cardiovascular Surgeapparent predilection of pleural plaques
for these regions.
If these suppositions hold weight,
then an obvious question arises. Is
there a place for prophylactic pleurod-
esis in the prevention of mesothelioma
by preventing chronic abrasion be-
tween the pleural surfaces?
The risk of development of meso-
thelioma in those with asbestos-
related disease has been quoted at
10%, a figure presumably subject to
much discussion. It may be arguable
whether even a procedure of low mor-
bidity should be universally proposed
as a panacea. However, other factors,
possibly including plaque load, life
expectancy, smoking, and chronic
cough, may enable identification of
higher risk groups for whom active in-
tervention may be justified.
Vincent Acton, FRANZCR
Sydney, Australia
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MEDIASTINAL LYMPH NODES
To the Editor:
We read with great interest the re-
sults of the American College of Sur-
gery Oncology Group (ACOSOG)
Z0030 trial,1 which was a randomized,
multi-institutional, prospective trial of
mediastinal lymph node dissection
(MLND) versus sampling (MLNS)
during pulmonary resection for pa-
tients with early-stage (N0 or nonhilar
N1, T1, or T2) non–small cell lung can-
cer (NSCLC). At a median follow-up
of 6.5 years, 44% died in the MLNS
arm and 42% died in the MLND arm,
and the median survival was 8.1 years
in the MLNS group and 8.5 years in
theMLNDgroup (P¼ .25). Studies ad-
dressing the survival benefit ofMLND,
however, have been inconclusive.
We herein performed a meta-analysis
of randomized controlled trials of
MLND versus MLNS during pulmo-
nary resection for prevention of all-
cause mortality in early-stage NSCLC.ry c Volume 142, Number 2 477
